Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice

FEMS Microbiology Letters

Volumn 186, Issue 1, 2000, Pages 121-126

  Kawakami, Kazuyoshi ^a   Koguchi, Yoshinobu ^a   Qureshi, Mahboob Hossain ^a   Kinjo, Yuki ^a   Yara, Satomi ^a   Miyazato, Akiko ^a   Kurimoto, Masashi ^b   Takeda, Kiyoshi ^c   Akira, Shizuo ^c   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cryptococcus neoformans; DTH; IL 12; IL 18; Th1 response

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; HELPER CELL; HOST RESISTANCE; INFECTION RESISTANCE; LUNG MYCOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; COLONY COUNT, MICROBIAL; CROSSES, GENETIC; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; LUNG; MICE; MICE, INBRED C57BL; SPLEEN; TH1 CELLS;

FILOBASIDIELLA NEOFORMANS;

EID: 0034194888     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00128-2     Document Type: Article

References (25)

1. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378:1995;88-91.
2. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:1998;281-312.
3. Zhang T., Kawakami K., Qureshi M.H., Okamura H., Kurimoto M., Saito A. Interleukin (IL)-12 and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of interferon-γ by natural killer cells. Infect. Immun. 65:1997;3594-3599.
4. Bohn E., Sing A., Zumbihl R., Bielfeldt C., Okamura H., Kurimoto M., Heesemann J., Autenrieth I.B. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:1998;299-307.
5. Mastroeni P., Clare S., Khan S., Harrison J.A., Hormaeche C.E., Okamura H., Kurimoto M., Dougan G. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67:1999;478-483.
6. Fujioka N., Akazawa R., Ohashi K., Fujii M., Ikeda M., Kurimoto M. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J. Virol. 73:1999;2401-2409.
7. Sugawara I., Yamada H., Kaneko H., Mizuno S., Takeda K., Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67:1999;2585-2589.
8. Wei X.B., Leung B.P., Niedbala W., Piedrfita D., Feng G., Sweet M., Dobbie L., Smith A.J.H., Liew F.Y. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163:1999;2821-2828.
9. Kawakami K., Qureshi M.H., Zhang T., Okamura H., Kurimoto M., Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. J. Immunol. 159:1997;5528-5534.
10. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 8:1998;383-390.
11. Decken K., Kohler G., Palmer-Lehmann K., Wunderlin A., Mattner F., Magram J., Gately M.K., Alber G. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:1998;4994-5000.
12. Kawakami K., Tohyama M., Teruya K., Kudeken N., Xie Q., Saito A. Contribution of interferon-γ in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. 13:1996;123-130.
13. Yuan R., Casadevall A., Oh J., Scharff M.D. T cell cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA. 94:1997;2483-2488.
14. Blackstock R., Buchanan K.L., Adesina A.M., Murphy J.W. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect. Immun. 67:1999;3601-3609.
15. Tranor T.R., Kuziel W.A., Huffnagle G.B. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2000;2021-2027.
16. Issekutz T.B., Stoltz J.M., Van der Meide P. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-γ J. Immunol. 140:1988;2889-2893.
17. Fong T.A., Mosmann T.R. The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143:1989;2887-2893.
18. Mu H.H., Sewell W.A. Regulation of DTH and IgE responses by IL-4 and IFN-γ in immunized mice given pertussis toxin. Immunology. 83:1994;639-645.
19. Cooper A.M., Magram J., Ferrante J., Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:1997;39-45.
20. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., Orme I.M. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178:1993;2243-2247.
21. Powrie F., Menon S., Coffman R.L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:1993;3043-3049.
22. Schwarz A., Grabbe S., Riemann H., Aragane Y., Simon M., Manon S., Andrade S., Luger T.A., Zlotnik A., Schwarz T. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103:1994;211-216.
23. Gartner Y.X., Zhu L., Wang S., Brunham R.C. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162:1999;1010-1017.
24. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:1998;83-243.
25. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T., Hartley S.B., Menon S., Kastelein R., Bazan F., O'Garra A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity. 7:1997;571-581.